Pilot Study of Optune for Recurrent Atypical and Anaplastic Meningioma Initiated
A pilot study is underway to evaluate the effects of the Optune device on recurrent atypical and anaplastic meningioma, which currently lacks effective treatments.
Therapeutic Area
Therapeutic area intelligence for Meningioma with 1 indexed intelligence signal across regulatory, clinical, competitive, and market developments.
No related entities indexed yet.
No catalysts indexed for this entity yet.
No related entities indexed yet.
Newsletter
Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.
No paywall. No spam. Unsubscribe anytime.